- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00216710
Evaluation of the Healthy Families Alaska Program
This study will assess the effectiveness of early home visitation by a professional in preventing child maltreatment, promoting healthy family functioning, and promoting child health and development.
The investigators will test the following hypotheses regarding the effectiveness of early paraprofessional home visiting for at-risk families
- Actual home visiting services adhere to HFAK standards.
- HFAK promotes healthy family functioning, promotes child health and development, and prevents child abuse and neglect.
- Adherence to HFAK process standards is positively associated with achievement of outcomes.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Healthy Families Alaska (HFAK) is a well-established child abuse prevention program targeted to at-risk families. HFAK is based on the Healthy Families America initiative promoted by Prevent Child Abuse America. The State Department of Health and Social Services (DHSS) administers the HFAK program.
In 1998, the Alaska State Legislature requested a controlled study of HFAK to determine its effectiveness in preventing child maltreatment, promoting healthy family functioning, and promoting child health and development. DHSS awarded the Johns Hopkins University School of Medicine a contract to conduct the study from July 1999 through June 2004.
The study is a randomized trial of six HFAK sites throughout Alaska. It aims to compare services actually provided to HFAK standards, assess program success in achieving intended outcomes, and relate program impact to service delivery.
Families are enrolled over 21 months beginning in January 2000. Families are randomized to either the HFAk group or the control group. Baseline data on family attributes are collected from HFAK files and maternal interviews. HFAK service data are collected from the program's management information system, record reviews, surveys of staff, and staff focus groups. Outcome data are collected when the children were two years old through maternal interview, home-based observations, child developmental testing, review of medical records, and review of OCS child welfare records.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Alaska
-
Anchorage, Alaska, Stati Uniti, 99503
- Johns Hopkins University
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Family resides in a community served by one of six HFAK programs participating in the study
- Family identified as at-risk by HFAK staff following the usual HFAK protocol
Exclusion Criteria:
- Family was previously enrolled in HFAK
- Mother unable to speak English well enough to complete study activities.
- Family unwilling to enroll in the HFAK program.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Sperimentale: Home Visited Mothers
Mothers randomized to the home visited group received AK State-funded home visiting services.
Frequency of home visits was determined by home visiting staff based on mothers' needs.
Mothers could receive home visiting services until their child turned 3 years old
|
|
Nessun intervento: Control Mothers
Mothers randomized to the control group did not receive home visiting services, but were offered referrals to other community-based services, as was usual protocol with home visiting agencies were operating at capacity.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Child Abuse and Neglect
Lasso di tempo: From child's birth (baseline) to 24 months of age
|
Substantiated and unsubstantiated reports of abuse; maternal self-report of harsh discipline
|
From child's birth (baseline) to 24 months of age
|
Child Development
Lasso di tempo: 24 months
|
Child cognitive, motor and psychosocial development
|
24 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Child Health
Lasso di tempo: From child's birth (baseline) to 24 months of age
|
Hospitalizations, ED use, injuries requiring medical care, adequate well child care, immunizations
|
From child's birth (baseline) to 24 months of age
|
Maternal Life Course
Lasso di tempo: At time of study follow-up (child 24 months of age)
|
Educational attainment, employment, social support, rapid repeat birth
|
At time of study follow-up (child 24 months of age)
|
Maternal Psychosocial Functioning
Lasso di tempo: At time of study follow-up (child 24 months of age)
|
Mental health, substance use, intimate partner violence
|
At time of study follow-up (child 24 months of age)
|
Parenting Knowledge
Lasso di tempo: At time of study follow-up (child 24 months of age)
|
Knowledge of child development; recognition of child delay
|
At time of study follow-up (child 24 months of age)
|
Parenting Attitudes
Lasso di tempo: At time of study follow-up (child 24 months of age)
|
Use of corporal punishment, infant caregiving, expectations of children, empathy towards child's needs
|
At time of study follow-up (child 24 months of age)
|
Parenting Behavior
Lasso di tempo: At time of study follow-up (child 24 months of age)
|
Observational measures of parent/child interaction and quality of the home environment, use of corporal punishment, use of nonviolent discipline
|
At time of study follow-up (child 24 months of age)
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Anne K Duggan, ScD, Johns Hopkins University
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- 99-0155
- Contract Number 067727
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Abuso di minori
-
MedDay Pharmaceuticals SAEurofins OptimedTerminatoVolontari sani | Compromissione epatica della categoria Child Pugh moderataFrancia, Ungheria
-
The Hospital for Sick ChildrenBill and Melinda Gates Foundation; Aga Khan UniversityAttivo, non reclutanteUnder Five Child Health Nutrizione e immunizzazionePakistan
-
RenJi HospitalCompletatoRapporto conta piastrinica/diametro milza | Classificazione Child-PughCina
-
Stanford UniversityNational Cancer Institute (NCI)TerminatoCarcinoma epatocellulare ricorrente | Child-Pugh Classe A | Child-Pugh Classe BStati Uniti, Giappone
-
Boehringer IngelheimNon più disponibileMalattie polmonari, interstiziali (nelle popolazioni pediatriche) | Malattia polmonare interstiziale infantile (chILD)
-
Ohio State University Comprehensive Cancer CenterVarian Medical SystemsCompletatoChild-Pugh Classe A | Carcinoma epatocellulare in stadio IIIA | Carcinoma epatocellulare in stadio IIIB | Carcinoma epatocellulare in stadio IIIC | Carcinoma epatocellulare in stadio IVA | Carcinoma epatocellulare in stadio IVB | Child-Pugh Classe BStati Uniti
-
Centre Hospitalier Universitaire DijonCompletatoCarcinoma epatocellulare di Child-Pugh AFrancia
-
Roswell Park Cancer InstituteMerck Sharp & Dohme LLCAttivo, non reclutanteCarcinoma epatocellulare adulto avanzato | Child-Pugh Classe A | Carcinoma epatocellulare in stadio III | Carcinoma epatocellulare in stadio IIIA | Carcinoma epatocellulare in stadio IIIB | Carcinoma epatocellulare in stadio IIIC | Carcinoma epatocellulare in stadio IV | Carcinoma epatocellulare in... e altre condizioniStati Uniti
-
AstraZenecaTerminatoTumore gastrico | Neoplasie solide avanzate | Tumore solido | Carcinoma epatocellulare avanzato di Child-Pugh da A a B7 | NSCLC con mutazione EGFR e/o ROS | Carcinoma da metastasi polmonariCorea, Repubblica di
Prove cliniche su Visita domiciliare
-
McGill UniversitySave the Children; European Network of Foundations Children and Violence Evaluation... e altri collaboratoriSconosciutoAbuso di minori | Relazioni genitori-figliCanada
-
Penn State UniversityUnited States Department of Agriculture (USDA)Reclutamento
-
University of MichiganCompletato
-
University of MichiganAttivo, non reclutanteSintomi comportamentali | Disordine depressivo | Depressione | Disturbi dell'umore | Disordine mentaleStati Uniti
-
University of MichiganAttivo, non reclutanteSintomi comportamentali | Disordini mentali | Disordine depressivo | Depressione | Disturbi dell'umoreStati Uniti
-
University of North Carolina, Chapel HillNational Institute of Nursing Research (NINR)CompletatoFragilità | Invecchiamento | Badante | Cura di transizione | Dimissione del pazienteStati Uniti
-
University College of Northern DenmarkAalborg UniversityCompletatoDiabete mellito, tipo 2 | Esercizio | Tecnologia
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completato
-
University Health Network, TorontoReclutamentoLinfoma | Malattie linfoproliferative | Cancro al seno Stadio I | Stadio del cancro al seno II | Cancro colorettale stadio II | Cancro colorettale Stadio III | Stadio del cancro al seno III | Cancro colorettale Stadio I | Stadio III del cancro della testa e del collo | Cancro al seno, stadio 0 | Tumore della... e altre condizioniCanada